The trademark application ADPERANZA was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on February 14, 2022, and it was registered by office on May 24, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).